Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 11.08.2026 FGBL.LN IE00BYTH6121  781,889.00 USD  81,101,686.33  103.725  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 11.08.2026 FKUD IE00BD9N0445  121,463.00 GBP   3,816,162.07   31.418  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 11.08.2026 FKU IE00B8X9NZ57  181,700.00 GBP   8,248,192.33   45.395  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 11.08.2026 FEUZ IE00B8X9NY41 1,647,274.00 EUR 109,209,623.41   66.297  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 11.08.2026 FEX.LN IE00B8X9NW27 1,388,395.00 USD 161,801,738.17 116.539  ...

HOUSTON--(BUSINESS WIRE)--HPE (NYSE: HPE) will conduct a live audio webcast of a conference call with analysts to review financial results for the third quarter of fiscal 2026, ending July 31, 2026. The call is scheduled for Wednesday, September 2 at 3:30 p.m. CT (4:30 p.m. ET), and the webcast will be available at www.hpe.com/investor/2026Q3Webcast. A replay of the webcast will be available at the same website shortly after the call and will remain available for approximately one year. For add...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 11.08.2026 FEM IE00B8X9NX34 300,002.00 USD 14,885,253.92 49.617  ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--A new survey reveals that U.S. biotechnology companies focused on developing treatments for rare and serious diseases overwhelmingly prefer to conduct first-in-human (FIH) clinical trials in the United States. However, historical obstacles posed by the U.S. Food and Drug Administration (FDA) are prompting them to seek development overseas – in Australia, Europe, and China. The survey of 37 U.S. biotechnology executives was conducted by the Biotech Consortium t...

HANGZHOU, China--(BUSINESS WIRE)--Ant Group today officially upgraded its physician platform, Haodf for Doctor, into AQ for Doctor, an AI-powered workstation designed to support physicians across every stage of clinical practice—from online consultations and patient management to clinical decision support and medical research. The platform is fully integrated with Ant Group's flagship AI health app, AQ, which serves more than 100 million users as of August 2026. Connecting doctors and patients...

AMSTERDAM--(BUSINESS WIRE)--Nebius Group N.V. (NASDAQ: NBIS), the AI cloud company, today announced its unaudited financial results for the three and six months ended June 30, 2026. The Company today also published founder and CEO Arkady Volozh’s quarterly letter to shareholders, available on its investor relations website at https://nebius.com/investor-hub. Management will hold an earnings webcast today at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time / 2:00 p.m. Central European Time). To re...